“…In fact, classical polyesters that are approved by the Food & Drug Administration for medical devices or drug formulations, like PLA, poly(glycolide) (PGA), PCL, and their copolymers, do not exhibit functional groups with exception to the terminal hydroxyl or carboxyl groups. To solve this lack of reactivity, various methods have been implemented including postpolymerization methods like wet chemistry under mild degrading conditions (aminolysis, hydrolysis) or plasma activation, and synthesis of lactones bearing functional groups . However, the postpolymerization strategies generally face problems of chain degradation and limited number of accessible reactive groups, whereas the lactone strategy faces problems of low yield due to multistep reactions and challenging purifications and, depending on the substituent, moderate to low monomer conversion and polymerization degrees.…”